Omicron variant escapes therapeutic mAbs contrary to eight prior main VOC
C. Boschi, P. Colson, A. Bancod, V. Moal, B. La Scola
The paper shows that the Omicron variant escapes neutralization by authorized mAbs, unlike previous variants, highlighting the need for updated protective measures for immunocompromised patients.
bioRxiv · Jan 3, 2022 · PreprintMicrobiology